latest news releases from the newsroom
Moventis Capital Reports Financial Results for Fiscal 2007 Second Quarter
VANCOUVER, British Columbia, Feb. 20, 2007 (PRIME NEWSWIRE) -- Moventis Capital, Inc. (OTCBB:MVTS), an acquisition and management company that acquires small and medium-sized private enterprises (SMEs) and provides resources and management to promote growth and enhance valuation, today announced that strong organic growth from its first acquired asset contributed to improving financial results for fiscal 2007 second quarter ended December 31, 2006.
SmallCap Sentinel: Betting On the Baby Boomers
IRVINE, Calif., Feb. 20, 2007 (PRIME NEWSWIRE) -- "Savvy investors are focusing on industries where the enormous population of aging Baby Boomers are now spending their money," stated SmallCap Sentinel analyst, D.R. Clark. "During the Baby Boomer years, approximately 76 million Americans were born. Today, this represents 28 percent of the American population. The aging of this demographic will naturally cause a greater consumption of imperative goods and services led most obviously by health care."
U.S. Mine Makers, Inc.
Nitro Lube, Inc. Announces 'Ontario Formula Ford Challenge' Sponsorship
LANGLEY, British Columbia, Feb. 20, 2007 (PRIME NEWSWIRE) -- Nitro Lube, Inc. (Pink Sheets:NLUB), proudly announced today that it has been accepted as a Corporate Lubricant Sponsor for the 2007 "Ontario Formula Ford Challenge" (http://www.offc.ca) racing season. "More that fifty race cars will sport Nitro Lube decals during the racing season. The Nitro Lube name will be seen by thousands of racing fans and our brand will be associated with top quality racing cars. Nitro Lube will be represented at the 'OFFC' Booth at the 2007 Toronto Auto Show this week. We look forward to this racing season as an excellent opportunity to promote the Nitro Lube name and its products," stated Jason Rite, President and CEO of NLUB.
Gerard McGarrity Joins VIRxSYS as Executive Vice President of Scientific and Clinical Affairs
GAITHERSBURG, Md., Feb. 20, 2007 (PRIME NEWSWIRE) -- VIRxSYS Corporation announced today that Gerard McGarrity, Ph.D., has joined the company as Executive Vice President of Scientific and Clinical Affairs. McGarrity will focus on the continued development of VRX496, the Company's initial product by managing the product development and implementation of VIRxSYS' clinical trials. The Company's first application of its novel lentiviral vector technology is an HIV gene therapy, VRX496, which has completed Phase I clinical trials. VIRxSYS currently has underway two separate Phase II trials to test the safety and tolerability of single and repeated doses of VRX496. Preliminary results from these trials will be available in 2007. In preclinical and Phase I clinical studies, VRX496 has been able to deliver genes permanently, reproducibly and efficiently to human cells without toxicity or serious adverse events, such as immunogenicity or insertional oncogenesis (cancer) which plagued earlier gene therapy trials.
NetFabric Holdings, Inc.
NetFabric Subsidiary, UCA Services, Inc., Announces An End-to-End SMB Help Desk Solution
DENVILLE, N.J., Feb. 20, 2007 (PRIME NEWSWIRE) -- UCA Services, Inc. (UCA), a wholly owned subsidiary of NetFabric Holdings, Inc. (OTCBB:NFBH), recently launched an aggressive sales and marketing campaign to help Small to Medium Business (SMB) clients better understand and utilize best practices as part of their Help Desk initiatives.